Cook Incorporated And Angiotech Pharmaceuticals (ANPI) Restructure License Agreement; Cook To Focus On Developing Paclitaxel-Eluting Medical Devices For Peripheral -- Non-Coronary -- Market
10/19/2005 5:10:55 PM
Cook Incorporated has restructured its license agreement with Angiotech regarding drug-eluting medical devices, the company announced today. The license agreement signed by Cook(R) and Angiotech in 1997 has been amended to accommodate Cook's decision to focus its product development efforts under the license on peripheral vascular and gastrointestinal drug-eluting medical devices.
comments powered by